奇正藏药品牌怎么样 申请店铺

我要投票 奇正藏药在医疗器械行业中的票数:566 更新时间:2025-08-11
奇正藏药是哪个国家的品牌?「奇正藏药」是 西藏奇正藏药股份有限公司 旗下著名品牌。该品牌发源于西藏林芝地区,由创始人雷董在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力奇正藏药品牌出海!将品牌入驻外推网,定制奇正藏药品牌推广信息,可以显著提高奇正藏药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

奇正藏药怎么样

十大伤药品牌,国内较大的藏药生产企业,以奇正消痛贴膏为代表的外用止痛药物畅销市场,专注于新型藏药的研发、生产和销售的高新技术企业。

西藏奇正藏药股份有限公司是国内大型的藏药生产企业,主要从事新型藏药的研发、生产和销售,现拥有GMP药厂、GSP营销公司等全资及控股子公司16家,拥有73个药品批准文号,涵盖了心脑血管、呼吸系统、消化系统、泌尿生殖系统、神经系统、骨骼肌肉系统、妇科疾患等领域的产品。

奇正藏药专注藏药产业,传统藏药的传承和创新,在安全、功效和质量方面挖掘高原药物的特有潜力,使产品不断进入主流市场、大众医疗机构,对人类和社会产生积极影响。被誉为中国光彩事业科技援藏的一面旗帜,传统藏药的传承和创新,经过十多年的发展,探索出千年藏药进行现代市场转化的成功模式,形成了自身的核心优势:  优秀的品牌建设、渠道营销、研发创新保障新产品储备、丰富的藏区资源、翔实的现代医药学研究、优质的财务状况和深厚的文化底蕴。奇正藏药拥有中国外用止痛贴膏品牌产品。2009年8月28日,奇正藏药发行A股在深交所正式挂牌交易。

The top ten brand of Traumatology medicine, the largest Tibetan medicine manufacturer in China, the best-selling market of external painkillers represented by Qizheng Xiaotong Plaster, and the high-tech enterprise focusing on the research, development, production and sales of new Tibetan medicine. Tibet Qizheng Tibetan Medicine Co., Ltd. is a large-scale Tibetan medicine manufacturer in China, mainly engaged in the research, development, production and sales of new Tibetan medicine. Now it has 16 wholly-owned and holding subsidiaries, including GMP pharmaceutical factory, GSP marketing company, and 73 drug approval numbers, covering cardio cerebrovascular, respiratory system, digestive system, urogenital system, nervous system, skeletal muscle system, gynecology Products in the field of diseases, etc. Qizheng Tibetan medicine focuses on the Tibetan medicine industry, inherits and innovates traditional Tibetan medicine, taps the unique potential of plateau medicine in terms of safety, efficacy and quality, makes products continuously enter the mainstream market and public medical institutions, and has a positive impact on human beings and society. Known as a banner of China's glorious cause of science and technology to aid Tibet, the inheritance and innovation of traditional Tibetan medicine, after more than ten years of development, has explored the successful mode of modern market transformation of Tibetan medicine in the millennium, and formed its own core advantages: excellent brand building, channel marketing, research and development innovation to guarantee new product reserves, rich Tibetan resources, detailed modern medical research High quality financial situation and profound cultural background. Qizheng Tibetan medicine has the brand product of Chinese external analgesic plaster. On August 28, 2009, Qizheng Tibetan Medicine issued A-share, which was officially listed on the Shenzhen Stock Exchange.

本文链接: https://brand.waitui.com/1d3b27bab.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

东风集团股份:1-7月累计汽车销量同比下降约8.9%

36氪获悉,东风集团股份发布公告,1-7月累计汽车销量为978462辆,同比下降约8.9%。其中,新能源汽车销量为249571辆,同比增长约35.5%。母公司东风汽车集团有限公司1-7月累计汽车销量为1260406辆,同比下降约10.8%。

2小时前

奇德新材:实控人拟减持公司不超2%股份

36氪获悉,奇德新材发布公告,公司控股股东、实控人饶德生计划以集中竞价、大宗交易方式,合计减持公司股份不超过167.91万股,即不超过公司扣除回购专户股份后总股本的2%。

2小时前

美股大型科技股盘前多数上涨,特斯拉涨超2%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,英特尔、特斯拉涨超2%,亚马逊涨0.39%,Meta涨0.19%,微软涨0.18%,奈飞涨0.11%;苹果跌0.52%,英伟达跌0.4%,谷歌跌0.23%。

2小时前

热门中概股美股盘前多数上涨,小鹏汽车涨超4%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,小鹏汽车涨超4%,哔哩哔哩、蔚来涨超2%,拼多多涨0.29%,百度涨0.21%;理想汽车跌超2%,京东跌0.76%,阿里巴巴跌0,02%。

2小时前

英伟达与AMD同意向美政府上缴15%的收入,外交部回应

8月11日,外交部发言人林剑答记者问。路透社记者提问,据报道,英伟达公司与超威半导体公司已同意向美国政府上缴在华芯片销售收入的15%,以换取对华出口许可证。中方对此有何评论?(英国广播公司亦问及)林剑表示,在美输华芯片问题上,中方已经多次表明了立场。(北京日报)

2小时前

本页详细列出关于奇正藏药的品牌信息,含品牌所属公司介绍,奇正藏药所处行业的品牌地位及优势。
咨询